Photo from Malak Alharbi/LinkedIn
Aug 6, 2024, 01:28
Malak Alharbi: Dual strategy of chemokine modulation followed by checkpoint inhibitors in TNBC
Malak Alharbi, Fellow at Roswell Park Comprehensive Cancer Center, shared on X about a recent paper by Malak Alharbi et al. titled “Targeting the tumor microenvironment to improve clinical outcomes in triple negative breast cancer patients and bridge the current disparity gap” published in PubMed Central.
“Excited to share our new article proposing a dual strategy of chemokine modulation followed by checkpoint inhibitors as an approach to address racial disparity within the TME of TNBC, especially among Black patients.”
Source: Malak Alharbi/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14